Kezar Life Sciences, Inc. Gains 52.15%
Fri, Oct 17, 2025 at 07:26 PM
Kezar Life Sciences, Inc. (KZR:NASDAQ) soared at $6.36, representing a gain of 52.2%. On Fri, Oct 17, 2025, KZR:NASDAQ hit a New 2-Week High of $6.36. The stock appeared on our News Catalysts scanner on Thu, Oct 16, 2025 at 06:56 PM in the 'MISCELLANEOUS' category. From Fri, Oct 03, 2025, the stock recorded 60.00% Up Days and 45.45% Green Days
About Kezar Life Sciences, Inc. (KZR:NASDAQ)
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.
Top 10 Gainers:
- Movella Holdings Inc. (MVLA:NASDAQ), 325%
- Rani Therapeutics Holdings, Inc. (RANI:NASDAQ), 248.27%
- Artiva Biotherapeutics, Inc. (ARTV:NASDAQ), 116.97%
- Kezar Life Sciences, Inc. (KZR:NASDAQ), 52.15%
- New Era Energy & Digital Inc Com (NUAI:NASDAQ), 44.44%
- Carbon Revolution Public Limited Company (CREV:NASDAQ), 43.36%
- VirnetX Holding Corp (VHC:NASDAQ), 40.41%
- VirnetX Holding Corporation (VHC:NYSE), 40.41%
- Latch, Inc. (LTCH:NASDAQ), 40%
- NextCure, Inc. (NXTC:NASDAQ), 37.13%